Juvenile Nasopharyngeal Angiofibroma Outcomes and Cost: Analysis of the Kids' Inpatient Database

• Published in: Annals of otology, rhinology & laryngology Vol. 129; no. 5; p. 498
• Main Authors: Yu, Justin, Choi, Jonathan S, Giannoni, Carla, Patel, Akash J, Gallagher, K Kelly
• Format: Journal Article
• Language: English
• Published: United States 01.05.2020
• Subjects: Adolescent; Angiofibroma - economics; Angiofibroma - epidemiology; Angiofibroma - therapy; Cost of Illness; Costs and Cost Analysis; Databases, Factual; Disease Management; Female; Follow-Up Studies; Hospitalization - economics; Humans; Incidence; Inpatients - statistics & numerical data; Male; Nasopharyngeal Neoplasms - economics; Nasopharyngeal Neoplasms - epidemiology; Nasopharyngeal Neoplasms - therapy; Retrospective Studies; Treatment Outcome; United States - epidemiology; United States; otolaryngology; skull base surgery; length of stay; otology; outcome studies; pediatric vascular malformations; juvenile nasopharyngeal angiofibroma
• ISSN: 1943-572X
• DOI: 10.1177/0003489419896597

To report trends in Juvenile Nasopharyngeal Angiofibroma (JNA) hospitalizations and identify key factors affecting treatment outcomes and cost of care in JNA patients. The Healthcare Cost and Utilization Project (HCUP) Kids' Inpatient Database was queried for all cases of JNA between the years of 1997 and 2016. Key factors extracted were patient demographics, geographic region, hospital size, teaching status, elective admissions, and number of diagnoses and procedures performed during the hospitalization. These elements were correlated to length of stay (LOS) and cost-per-day (CPD) using a multiple linear regression (MLR). Regional variation in JNA diagnosis and changes in LOS and CPD trends over time were also analyzed. A total of 614 JNA patients were hospitalized in this time period, with a majority of patients identifying as male (98%) and Caucasian/White (55%). The average LOS has decreased by 0.14 day per year since 1997 (  = .0034) whereas the CPD has steadily increased by $2 380 per year (  < .001). MLR analysis revealed that while holding all other factors constant, patients who stayed at teaching hospitals had an increased LOS of 1.7 days (  = .026), but paid $11 961 less per day (  = .05). Regional variation in CPD was found in the Northeast region, where hospitalizations were more expensive by $9 801 per day compared to the South (  = .017). These results indicate hospital characteristics, such as teaching status and geographic region, may predict differences in JNA outcomes and cost. Healthcare providers should be cognizant of these variations to ensure optimal patient outcomes and expenditures.